University Hospitals Birmingham NHS Foundation Trust

Medicines A–Z

T

Status Drug name NICE TAs Comments
Status: Green Tolterodine tablets
Status: Amber Tolvaptan (Jinarc®)

Tolvaptan (Jinarc) for treating autosomal dominant polycystic kidney disease

Status: Red Tolvaptan (Samsca®)

Consultant advice only. Tolvaptan (Samsca) for the treatment of adult patients with hyponatraemia secondary to syndrome of inappropriate antidiuretic hormone secretion (SIADH).

Status: Amber Topiramate tablets

Prophylaxis of migraine. Specialist recommendation.

Status: Red Topotecan capsules

For hospital use only

Status: Amber Toripamate tablets
Status: Trabectedin injection
Status: Red Tramadol
Status: Green Tramadol capsules

Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties.

Status: Green Tramadol soluble tablets

Second line after morphine and codeine. Soluble tablets - high relative cost - patients with swallowing difficulties.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.

Building healthier lives
Back to top